Hrt Financial LP Zai Lab LTD Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$15.95 - $26.8 $14,961 - $25,138	-938 Reduced 3.22%	28,216 $452,000
Q4 2023 Feb 09, 2024	SELL	$22.97 - $30.58 $1.4 Million - $1.86 Million	-60,769 Reduced 67.58%	29,154 $796,000
Q3 2023 Nov 13, 2023	BUY	$22.72 - $31.49 $2.04 Million - $2.83 Million	89,923 New	89,923 $2.19 Million
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $533,957 - $1.02 Million	-9,726 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $328,650 - $558,298	3,130 Added 47.45%	9,726 $1.03 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $825,225 - $1.19 Million	6,596 New	6,596 $1.17 Million

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.